TOURAJ YARI: Open Payments
NPI 1508214958 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,644 in 273 payments from 41 companies in 2025. Trend: 2023 $4,485 · 2024 $5,205 · 2025 $5,644
Food & beverage: $5,583Education: $61
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 41 | $948 |
| ABBVIE INC. | 36 | $507 |
| Lundbeck LLC | 11 | $316 |
| Biogen, Inc. | 13 | $312 |
| Neurelis, Inc. | 18 | $307 |
| Teva Pharmaceuticals USA, Inc. | 11 | $211 |
| TG Therapeutics, Inc. | 9 | $201 |
| PFIZER INC. | 18 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $166 |
| Axsome Therapeutics, Inc. | 7 | $156 |
Products named: Zilbrysq, LEQEMBI, VYEPTI, VALTOCO, QULIPTA, Fintepla, AUSTEDO XR, UBRELVY.
Industry payments across CA — which companies pay providers there.
